Equities

Biogen Inc

0R1B:LSE

Biogen Inc

  • Price (USD)199.18
  • Today's Change13.17 / 7.08%
  • Shares traded1.47k
  • 1 Year change38.89%
  • Beta0.1510
Data delayed at least 20 minutes, as of Feb 06 2026 19:11 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Income statement information is not available for Biogen Inc.
Gross margin75.24%
Net profit margin15.98%
Operating margin21.91%
Return on assets5.59%
Return on equity9.31%
Return on investment6.59%
More ▼

Cash flow in USDView more

In 2025, Biogen Inc increased its cash reserves by 26.67%, or 633.50m. The company earned 2.20bn from its operations for a Cash Flow Margin of 22.29%. In addition the company used 1.37bn on investing activities and also paid 301.90m in financing cash flows.
Cash flow per share16.18
Price/Cash flow per share12.44
Book value per share124.11
Tangible book value per share16.26
More ▼

Balance sheet in USDView more

Biogen Inc has a Debt to Total Capital ratio of 25.66%, a lower figure than the previous year's 27.79%.
Current ratio2.72
Quick ratio2.04
Total debt/total equity0.3452
Total debt/total capital0.2566
More ▼

Growth rates in USD

SmartText is unavailable
EPS growth(5 years)-18.66
EPS (TTM) vs
TTM 1 year ago		-0.9033
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.